4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-18-045405
Chief Business Officer bought 500 shares at $2.71 ($1,355)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Longcor Jarrod Chief Business Officer | 2018-08-16 | Purchase | +500 | $2.71 | $1,355 | 7,200 | D |
| Open-market purchases · 500 sh · avg $2.71 · $1,355 | |||||||
Loading xslF345X03/tv501325_form4.xml…